Clinical Characteristics of Coexisting Pulmonary Thromboembolism in Patients With Respiratory Tuberculosis.
OBJECTIVE
Data regarding coexisting pulmonary thromboembolism (PTE) in patients with tuberculosis are limited. The aim of this study was to investigate the clinical features of coexisting PTE in patients with respiratory tuberculosis.


METHODS
Clinical parameters were retrospectively compared between the tuberculosis group (PTE and coexisting respiratory tuberculosis) and unprovoked or provoked group selected from a single institution in South Korea, a country that has an intermediate tuberculosis burden.


RESULTS
Twenty-four patients with PTE and concomitant respiratory tuberculosis were identified. These patients accounted for 1.0% of 2,386 patients with respiratory tuberculosis and 2.8% of 867 PTE patients who were enrolled over the same period. Compared with the unprovoked group, the tuberculosis group had significantly lower body mass index, higher levels of blood inflammatory markers and higher pulmonary embolism severity index (PESI) with a higher incidence of high PESI class (≥3). The tuberculosis group had a significantly lower incidence of central PTE than the unprovoked group, but the rate of right ventricular dilation on computed tomography scan was not significantly different between the 2 groups. Adverse outcomes, PTE-related in-hospital mortality and the recurrence of venous thromboembolism were not significantly different between the tuberculosis and unprovoked or provoked group.


CONCLUSIONS
The coexistence of PTE and respiratory tuberculosis rarely occurred in clinical practice. Compared with unprovoked PTE, PTE with respiratory tuberculosis is characterized by lower body mass index, higher levels of blood inflammatory markers, higher PESI and less frequent central PTE, but it is not associated with any differences in outcomes caused by PTE.
Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea.
Hyeyoung
H
Park
Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea. Electronic address: sicha@knu.ac.kr.
Seung-Ick
SI
Cha
Department of Radiology, Kyungpook National University School of Medicine, Daegu, Korea.
Jae-Kwang
JK
Lim
Department of Radiology, Gyeongsang National University School of Medicine, Jinju, Korea.
Kyung
K
Nyeo Jeon
Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea.
Seung-Soo
SS
Yoo
Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea.
Jaehee
J
Lee
Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea.
Shin-Yup
SY
Lee
Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea.
Chang-Ho
CH
Kim
Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea.
Jae-Yong
JY
Park
D000368:Aged; D000995:Antitubercular Agents / Q000494:pharmacology; D001799:Blood Sedimentation; D002097:C-Reactive Protein / Q000032:analysis; D015897:Comorbidity; D024881:Drug Resistance, Bacterial; D018432:Drug Resistance, Multiple; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D011655:Pulmonary Embolism / Q000097:blood / Q000000981:diagnostic imaging / Q000453:epidemiology* / Q000382:microbiology; D056910:Republic of Korea / Q000453:epidemiology; D014057:Tomography, X-Ray Computed; D014397:Tuberculosis, Pulmonary / Q000097:blood / Q000000981:diagnostic imaging / Q000453:epidemiology* / Q000382:microbiology
D000995:Antitubercular Agents; D002097:C-Reactive Protein; D007538:Isoniazid
Computed tomography; Pulmonary embolism; Treatment outcome; Tuberculosis